Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
2 clinical trials · Condition
◉ Watch Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma (NCT07691450) | City of Hope Medical Center | 2027-01-03 |
| Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas (NCT03598998) | City of Hope Medical Center | 2019-02-04 |
Track Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.